Drugs / Viraferon-peg
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Withdrawn | EU (EMA) | ViraferonPeg | — | 2021-01-11 | europa.eu ↗ |
| Approved | EU (EMA) | ViraferonPeg | — | 2000-05-28 | europa.eu ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT00723242 Background | Apr 2002 → Dec 2004 | chronic hepatitis C virus infection | University College, London | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Viraferon-peg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00723242 ↗ |